table of content
1 Introduction to Research & Analysis Reports
1.1 Autologous Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Biologics Overall Market Size
2.1 Global Autologous Biologics Market Size: 2022 VS 2030
2.2 Global Autologous Biologics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Autologous Biologics Sales: 2018-2030
3 Company Landscape
3.1 Top Autologous Biologics Players in Global Market
3.2 Top Global Autologous Biologics Companies Ranked by Revenue
3.3 Global Autologous Biologics Revenue by Companies
3.4 Global Autologous Biologics Sales by Companies
3.5 Global Autologous Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Autologous Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Autologous Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autologous Biologics Players in Global Market
3.8.1 List of Global Tier 1 Autologous Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Autologous Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Biologics Market Size Markets, 2022 & 2030
4.1.2 Adipose Tissue
4.1.3 Plasma
4.1.4 Others
4.2 By Type - Global Autologous Biologics Revenue & Forecasts
4.2.1 By Type - Global Autologous Biologics Revenue, 2018-2023
4.2.2 By Type - Global Autologous Biologics Revenue, 2023-2030
4.2.3 By Type - Global Autologous Biologics Revenue Market Share, 2018-2030
4.3 By Type - Global Autologous Biologics Sales & Forecasts
4.3.1 By Type - Global Autologous Biologics Sales, 2018-2023
4.3.2 By Type - Global Autologous Biologics Sales, 2023-2030
4.3.3 By Type - Global Autologous Biologics Sales Market Share, 2018-2030
4.4 By Type - Global Autologous Biologics Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Autologous Biologics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Centers
5.1.4 Research Centers
5.2 By Application - Global Autologous Biologics Revenue & Forecasts
5.2.1 By Application - Global Autologous Biologics Revenue, 2018-2023
5.2.2 By Application - Global Autologous Biologics Revenue, 2023-2030
5.2.3 By Application - Global Autologous Biologics Revenue Market Share, 2018-2030
5.3 By Application - Global Autologous Biologics Sales & Forecasts
5.3.1 By Application - Global Autologous Biologics Sales, 2018-2023
5.3.2 By Application - Global Autologous Biologics Sales, 2023-2030
5.3.3 By Application - Global Autologous Biologics Sales Market Share, 2018-2030
5.4 By Application - Global Autologous Biologics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Autologous Biologics Market Size, 2022 & 2030
6.2 By Region - Global Autologous Biologics Revenue & Forecasts
6.2.1 By Region - Global Autologous Biologics Revenue, 2018-2023
6.2.2 By Region - Global Autologous Biologics Revenue, 2023-2030
6.2.3 By Region - Global Autologous Biologics Revenue Market Share, 2018-2030
6.3 By Region - Global Autologous Biologics Sales & Forecasts
6.3.1 By Region - Global Autologous Biologics Sales, 2018-2023
6.3.2 By Region - Global Autologous Biologics Sales, 2023-2030
6.3.3 By Region - Global Autologous Biologics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Autologous Biologics Revenue, 2018-2030
6.4.2 By Country - North America Autologous Biologics Sales, 2018-2030
6.4.3 US Autologous Biologics Market Size, 2018-2030
6.4.4 Canada Autologous Biologics Market Size, 2018-2030
6.4.5 Mexico Autologous Biologics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Autologous Biologics Revenue, 2018-2030
6.5.2 By Country - Europe Autologous Biologics Sales, 2018-2030
6.5.3 Germany Autologous Biologics Market Size, 2018-2030
6.5.4 France Autologous Biologics Market Size, 2018-2030
6.5.5 U.K. Autologous Biologics Market Size, 2018-2030
6.5.6 Italy Autologous Biologics Market Size, 2018-2030
6.5.7 Russia Autologous Biologics Market Size, 2018-2030
6.5.8 Nordic Countries Autologous Biologics Market Size, 2018-2030
6.5.9 Benelux Autologous Biologics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Autologous Biologics Revenue, 2018-2030
6.6.2 By Region - Asia Autologous Biologics Sales, 2018-2030
6.6.3 China Autologous Biologics Market Size, 2018-2030
6.6.4 Japan Autologous Biologics Market Size, 2018-2030
6.6.5 South Korea Autologous Biologics Market Size, 2018-2030
6.6.6 Southeast Asia Autologous Biologics Market Size, 2018-2030
6.6.7 India Autologous Biologics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Autologous Biologics Revenue, 2018-2030
6.7.2 By Country - South America Autologous Biologics Sales, 2018-2030
6.7.3 Brazil Autologous Biologics Market Size, 2018-2030
6.7.4 Argentina Autologous Biologics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Autologous Biologics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Autologous Biologics Sales, 2018-2030
6.8.3 Turkey Autologous Biologics Market Size, 2018-2030
6.8.4 Israel Autologous Biologics Market Size, 2018-2030
6.8.5 Saudi Arabia Autologous Biologics Market Size, 2018-2030
6.8.6 UAE Autologous Biologics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Vericel Corporation
7.1.1 Vericel Corporation Corporate Summary
7.1.2 Vericel Corporation Business Overview
7.1.3 Vericel Corporation Autologous Biologics Major Product Offerings
7.1.4 Vericel Corporation Autologous Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Vericel Corporation Key News
7.2 BioTime, Inc.
7.2.1 BioTime, Inc. Corporate Summary
7.2.2 BioTime, Inc. Business Overview
7.2.3 BioTime, Inc. Autologous Biologics Major Product Offerings
7.2.4 BioTime, Inc. Autologous Biologics Sales and Revenue in Global (2018-2023)
7.2.5 BioTime, Inc. Key News
7.3 Pharmicell Co.
7.3.1 Pharmicell Co. Corporate Summary
7.3.2 Pharmicell Co. Business Overview
7.3.3 Pharmicell Co. Autologous Biologics Major Product Offerings
7.3.4 Pharmicell Co. Autologous Biologics Sales and Revenue in Global (2018-2023)
7.3.5 Pharmicell Co. Key News
7.4 BrainStorm Cell Therapeutics
7.4.1 BrainStorm Cell Therapeutics Corporate Summary
7.4.2 BrainStorm Cell Therapeutics Business Overview
7.4.3 BrainStorm Cell Therapeutics Autologous Biologics Major Product Offerings
7.4.4 BrainStorm Cell Therapeutics Autologous Biologics Sales and Revenue in Global (2018-2023)
7.4.5 BrainStorm Cell Therapeutics Key News
7.5 Opexa Therapeutics, Inc
7.5.1 Opexa Therapeutics, Inc Corporate Summary
7.5.2 Opexa Therapeutics, Inc Business Overview
7.5.3 Opexa Therapeutics, Inc Autologous Biologics Major Product Offerings
7.5.4 Opexa Therapeutics, Inc Autologous Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Opexa Therapeutics, Inc Key News
7.6 Pharmicell Co., Inc
7.6.1 Pharmicell Co., Inc Corporate Summary
7.6.2 Pharmicell Co., Inc Business Overview
7.6.3 Pharmicell Co., Inc Autologous Biologics Major Product Offerings
7.6.4 Pharmicell Co., Inc Autologous Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Pharmicell Co., Inc Key News
7.7 Neostem
7.7.1 Neostem Corporate Summary
7.7.2 Neostem Business Overview
7.7.3 Neostem Autologous Biologics Major Product Offerings
7.7.4 Neostem Autologous Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Neostem Key News
7.8 Dendreon Corporation
7.8.1 Dendreon Corporation Corporate Summary
7.8.2 Dendreon Corporation Business Overview
7.8.3 Dendreon Corporation Autologous Biologics Major Product Offerings
7.8.4 Dendreon Corporation Autologous Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Dendreon Corporation Key News
7.9 Regenexx
7.9.1 Regenexx Corporate Summary
7.9.2 Regenexx Business Overview
7.9.3 Regenexx Autologous Biologics Major Product Offerings
7.9.4 Regenexx Autologous Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Regenexx Key News
7.10 Cytori Therapeutics
7.10.1 Cytori Therapeutics Corporate Summary
7.10.2 Cytori Therapeutics Business Overview
7.10.3 Cytori Therapeutics Autologous Biologics Major Product Offerings
7.10.4 Cytori Therapeutics Autologous Biologics Sales and Revenue in Global (2018-2023)
7.10.5 Cytori Therapeutics Key News
8 Global Autologous Biologics Production Capacity, Analysis
8.1 Global Autologous Biologics Production Capacity, 2018-2030
8.2 Autologous Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Autologous Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autologous Biologics Supply Chain Analysis
10.1 Autologous Biologics Industry Value Chain
10.2 Autologous Biologics Upstream Market
10.3 Autologous Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autologous Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
